Should You Buy the Dip in Procter & Gamble via ETFs?

One of the most famous names in the consumer products world – Procter & Gamble PG – came up with mixed-to-downbeat results for the third quarter of fiscal 2017. Naturally, shares remained muted post earnings. Let’s delve a little deeper into the results and assess what could be done with P&G shares in the coming days.

Procter & Gamble's 3Q17 Earnings in Focus
 
The consumer staple giant’s 3Q17 adjusted earnings of $0.96 per share beat the Zacks Consensus Estimate of $0.94 by 2.1%. The bottom line also increased 12% from the prior-year quarter. Currency-neutral core EPS improved 15%.

P&G’s reported net sales of $15.61 billion missed the Zacks Consensus Estimate of $15.71 billion by 0.7%. The top line also declined 1% year over year. Foreign exchange had a negative impact of 2% on sales.

Organically (excluding the impact of acquisitions, divestitures and foreign exchange), revenues grew 1% on the back of a 1% increase in organic volumes. Core gross margin decreased 40 bps to 50.5% as productivity cost was more than offset by headwinds like an unfavorable geographic and product mix.

Management maintained its organic sales growth projection in the range of 2–3% for fiscal 2017. However, the company expects the combined foreign exchange headwind and minor brand divestitures to hurt sales by 2–3%. Hence, P&G expects all-in sales growth to remain down 1% to flat (earlier flat) for fiscal 2017.

The company has beefed up its guidance for adjusted free cash flow productivity from 90% to approximately 95% for the fiscal year.

Consumer ETF Impact

Thanks to mixed results, shares of PG dropped about 2.6% in the last two trading sessions (as of April 27, 2017). The loss also reflected in the ETF world, with consumer staples funds being slightly hurt. Many of the key funds in this segment have a double-digit allocation to the consumer product giant, suggesting that the performance of the fund is highly dependent on P&G’s performance.

Let’s take a look at the following three ETFs with a solid allocation to Procter & Gamble (read: Consumer Staples ETF Investing 101):

Consumer Staples Select Sector SPDR Fund XLP

The most popular consumer ETF on the market, XLP, follows the S&P Consumer Staples Select Sector Index. The fund invests about $9 billion of assets in 39 holdings. Of these firms, the in-focus P&G takes the first spot, making up roughly 12% of the assets. The fund lost about 0.9% in the last two trading sessions (as of April 27, 2017) (see all consumer staples ETFs here).